Chr. Hansen Holding A/S

Chr. Hansen Holding A/S

Chr. Hansen Holding A/S

Overview
Date Founded

2004

Headquarters

Bøge Allé 10-12,Hørsholm, Capital Region 2970

Type of Company

Public

Employees (Worldwide)

2,852

Industries

Biotechnology
Chemicals

Company Description

Chr. Hansen Holding A/S is a bioscience company, which engages in the development of natural solutions for the food, nutritional, pharmaceutical, and agricultural industries. It operates through the following segments: Food Cultures and Enzymes; Health and Nutrition; and Natural Colors. The Food Cultures and Enzymes segment produces and sells cultures, enzymes, and probiotic products that help determine the taste, flavor, texture, shelf life, nutritional value, and health benefits of consumer products in the food industry. The Health and Nutrition segment manufactures and distributes products for the dietary supplement, over-the-counter pharmaceutical, infant formula, animal feed, and plant protection industries. The Natural Colors segment caters to the food and beverage industry. The company was founded by Christian Ditlev Ammentorp Hansen in 1874 and is headquartered in Hørsholm, Denmark.

Contact Data
Trying to get in touch with decision makers at Chr. Hansen Holding A/S? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

President & Chief Executive Officer

Chief Financial Officer & Executive Vice President

Executive Vice President

Executive Vice President of the Asia-Pacific & Latin American Regions

Group Vice President, EMEA

Executive Vice President of the Natural Colors Division

Executive Vice President, Global Operations

Executive Vice President & CSO-Executive Board Member

Executive Vice President, Health & Nutrition

Vice President-Strategy & Business Development

Board of Directors

Former Chairman of the Board-Europe Group at The Coca-Cola Company

Former Executive Vice President & Head of BioPharm & Global Legal & Patents at Novo Nordisk A/S

President & Chief Executive Officer at Coloplast A/S

Former Executive Vice President & Head of Zone EMENA at Nestlé SA

Former Managing Director-Asia, Africa & Middle East at Fonterra Co-operative Group Ltd.

Global Freeze Drying Technology Coordinator at Chr. Hansen Holding A/S

Former Senior Vice President-Global Foods Research & Development at PepsiCo, Inc.

Deputy Chief Executive Officer at Novo Nordisk Fonden

Professional at Chr. Hansen Holding A/S

Project Manager at Chr. Hansen A/S

Paths to Chr. Hansen Holding A/S
Potential Connections via
Relationship Science
You
Chr. Hansen Holding A/S
Owners & Shareholders
Details Hidden

WCM employs a bottom-up, fundamental method of analysis that emphasizes long-horizon growth prospects, competitive advantages, and company cultures conducive to attracting great people. Valuation also plays an important factor in the firm's analysis method, predominantly impacting the timing of decisions and portfolio position sizing. Their strategies utilize different capitalization ranges (e.g., large-cap, small-cap, all-cap,) different geographical scopes (e.g., international, global, emerging markets, US domestic) and different security types (e.g., foreign ordinary shares, ADR). WCM's Investment Strategy Group (ISG), consisting of senior investment professionals, makes all portfolio decisions.

Details Hidden

GLG-UK is an active, collaborative manager which aims to achieve consistent superior returns. They adhere to client-focused product development and customer service in both traditional and alternative asset management. The firm's fund managers express their individual investment styles and meet regularly with companies, brokers and consultants, analyzing quantitative models or completing their own proprietary research. They base investment decisions on fundamental research, tactical trading and a wide range of network of industry contacts and employ a rigorous risk management process.

Details Hidden

ATP is an active, long-term, fundamentals-based manager which allocates assets among domestic and foreign bonds, equities, real estate and infrastructure in order to generate as high a return as possible for the pensioners. In addition to ensuring high returns, the firm also invests based on a philosophy of social responsibility in investments. This means that ATP only invests in companies that comply with legislation and international conventions. The way ATP invests includes the following four key elements: (1) hedging of the interest rate risk on pension commitments; (2) effective risk diversification of return on the investment portfolio must be stable and as independent of the business cycle as possible. Therefore, ATP spreads the risk as effectively as possible around four risk factors; (3) focus on strong investment processes; and (4) appropriate level of risk are regularly adjusted in relation to the size of ATP's reserves.

Recent Transactions
Details Hidden

Chr. Hansen Holding A/S purchases Österreichische Laberzeugung Hundsbichler GmbH

Details Hidden

Chr. Hansen Holding A/S purchases Valio Oy /LGG Business from Valio Oy

Details Hidden

Chr. Hansen Holding A/S purchases Nutrition Physiology Co. LLC from The Halifax Group LLC

Transaction Advisors
Underwriter

Advised onChr. Hansen Holding A/S issued Ordinary Shares

Underwriter

Advised onChr. Hansen Holding A/S issued Ordinary Shares

Global Coordinator

Advised onChr. Hansen Holding A/S issued Ordinary Shares

Clients

Alkaloid AD Skopje engages in the production and sale of pharmaceutical, chemical and cosmetic products, as well as goods from herbal origin. It operates through the following segments: Pharmaceuticals, Chemicals, Cosmetics, and Botanicals. The Pharmaceuticals segment involves in producing medicines for human use including oral hard dosage forms, liquid dosage forms for oral administration, topical preparations, and sterile dosage forms. The Chemicals segment offers production of chemicals products, organic and non-organic reagents, with pa, puriss, purum, and with pharmacopeial qualities. The Cosmetics segment includes producing and selling of cosmetics including skincare products, children's skincare, soaps, hair care products, dental care products, men's perfume collection, women's perfume collection, as well as household cleaners. The Botanicals segment comprises of producing botanical products by processing, blending, and packing herbal materials like roots, leaves, fruits, and seeds. The company was founded in 1936 and is headquartered in Skopje, Macedonia.

Key Stats and Financials As of 2018
Market Capitalization
$93B
Total Enterprise Value
$90.8B
Earnings Per Share
$12.88
Revenue
$8.17B
Net Profit
$1.7B
EBITDA
$2.84B
EBITDAMargin
34.75%
Total Debt
$5.43B
Total Equity
$5.75B
Enterprise Value Sales
11.12x
Enterprise Value EBITDAOperating
31.99x
TEVNet Income
53.46x
Debt TEV
0.06x
Three Year Compounded Annual Growth Rate Of Revenue
8.5%
Five Year Compounded Annual Growth Rate Of Revenue
8.22%
Investors
Details Hidden

Ardian is an active manager which focuses exclusively on investing in unlisted companies and managing assets on behalf of third parties, aiming to provide long-term returns.The firm invests in buyouts of profitable high-potential companies valued between EUR 100 million and EUR 2 billion, generally taking a controlling interest, aiming to increase their growth and earnings in new markets.Ardian seeks to take controlling interests in small-cap buyouts in France, Germany and Italy, partnering with the investee company to add value and boost growth. They provide expansion capital by investing via minority interests in mature, profitable companies.Their Venture Capital team raises funds and consults innovative high-potential companies in the high-tech life sciences sector, making minority interest investments of EUR 2-5 million after receiving approval from the investment committee.They co-invest in buyout transactions involving companies valued at over EUR 500 million. The investment team constructs a diversified portfolio by sector, country, volume and type of transaction, taking minority interests in major LBOs in Europe and the US.For fund of funds, the firm performs in-house research, including track record, organization, employees and a review of individual assets in the portfolios, aiming to optimize investment in the best North American, European and Asian private equity funds.Ardian makes direct mezzanine investment in Europe as lead, co-investment and minority investor, partnering with other mezzanine funds to promote co-investment deals and increase the regional diversification of their portfolios.Their infrastructure team makes long-term investments of up to EUR 150 million in the transport, energy, water distribution and waste treatment sectors in European companies whose activity generates stable, foreseeable cash-flows.

Details Hidden

PAI is an active manager which focuses their investments on businesses with a strong European presence. The firm makes controlling equity investments in LBOs with transaction values generally between €500 million and several billion euros, aiming to invest in medium- to large-size public or private European companies in the services, consumer goods and capital goods sectors which have market leadership positions and an outstanding management team.PAI partners with their investee companies, aiming to add value by supporting the implementation of strategic and operational improvements, refocusing activities, targeting capital expenditure, marketing and R&D investments, evaluating new business opportunities, identifying add-on acquisitions and utilizing their network of industrial and financial contacts.While the firm participates actively in the key strategic decisions of their investee companies, they leave management in charge of the day-to-day running of the business and offer them attractive equity stakes and competitive performance-based compensation.

Suppliers
Novozymes A/S Other Business & Consulting Services | Copenhagen, CR

Novozymes A/S engages in the research and development of biotechnology solutions, which produces industrial enzymes and microorganisms. Its business areas include agriculture, bioenergy, biopharma, food and beverage, household care, leather, pulp and paper, textile and wastewater solutions. The company was founded in 2000 and is headquartered in Copenhagen, Denmark.

Neogen Corp. Hospitals & Patient Services | LANSING, MI

Founded in 1982, Neogen Corporation (NASDAQ: NEOG) has grown to more than 600 employees in multiple U.S. and international locations, and a worldwide presence. Neogen develops, manufactures and markets a diverse line of products dedicated to food and animal safety. The Company’s Lansing, Mich.-based Food Safety Division develops and markets dehydrated culture media, and rapid diagnostic test kits to detect foodborne bacteria, spoilage organisms, mycotoxins, food allergens, genetic modifications, drug residues, plant diseases, and sanitation concerns. Neogen’s Lexington, Ky.-based Animal Safety Division develops and markets a complete line of diagnostics, veterinary instruments, veterinary pharmaceuticals, nutritional supplements, disinfectants, and rodenticides. Neogen’s GeneSeek subsidiary based in Lincoln, Neb., is the leading global provider of DNA testing for animal agribusiness and veterinary medicine. Neogen understands that its customers face serious consequences if their products are contaminated with any of a number of well-established or emerging threats, including dangerous bacteria, natural toxins, veterinary drug residues, unlabeled food allergens, rodent filth, sanitation concerns, broken veterinary needles or other contaminants. Neogen excels at helping to identify safety concerns in the vast and changing landscape of food and animal safety. Neogen sales representatives can help customers address a wide array of concern with a “one-stop shop” approach that is a big advantage in a business climate trending toward single-source suppliers. The company now has more than 200 diagnostic tests to offer customers, and a comprehensive line of complementary products and services, such as dehydrated culture media to go with unmatched customer support and training. Neogen employs a similar marketing strategy for its veterinary products, offering customers a wide variety of animal safety solutions. Neogen believes that maintaining earned trust is a combination of innovation and a continuous commitment to quality. Neogen’s quality management system is ISO 9001 certified, which communicates to the company’s worldwide customer base that it understands the quality standards customers expect, and is firmly committed to achieving those quality standards. In recognition of this success, Neogen has been repeatedly named to Forbes Magazine’s list of the Best Small Companies in America, and was chosen by the NASDAQ National Market to be included in its top tier of listed companies, the Global Select Market.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Chr. Hansen Holding A/S. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Chr. Hansen Holding A/S's profile does not indicate a business or promotional relationship of any kind between RelSci and Chr. Hansen Holding A/S.
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/organization/chr-hansen-holding-as-1324377
  • https://relationshipscience.com/organization/chr-hansen-holding-as-1324377